A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Histone tails undergo post-translational modifications (acetylation by HATs, methylation by HMTs, phosphorylation, ubiquitination) that alter nucleosome stability, recruit co-regulatory proteins, and regulate transcription. These modifications form an 'epigenetic code' that is maintained through cell divisions, providing cellular memory independent of DNA sequence. H3K9ac and H3K4me3 mark active promoters; H3K27me3 marks Polycomb-repressed genes. Dysregulation of histone modifying enzymes drives cancer and developmental disease; these enzymes are now major therapeutic targets.
You already know that chromatin remodeling controls whether genes are accessible or locked away — that nucleosomes can slide, eject, or tighten to open or close stretches of DNA. Histone modifications are the chemical signals that direct much of this remodeling. Each nucleosome's histone proteins have flexible "tails" that protrude outward, and enzymes can attach small chemical groups to specific amino acids on these tails. The most common modifications are acetylation (adding an acetyl group, typically to lysine residues) and methylation (adding one, two, or three methyl groups). But phosphorylation and ubiquitination also play important roles. Each modification changes how tightly the histone grips DNA or which regulatory proteins are recruited to that region.
The logic works like a signaling code. Histone acetyltransferases (HATs) add acetyl groups that neutralize the positive charge on lysine residues, weakening the electrostatic attraction between histones and the negatively charged DNA backbone. The result is a more open, accessible chromatin state — euchromatin — where transcription machinery can bind. Conversely, histone deacetylases (HDACs) remove acetyl groups, re-tightening the chromatin. Methylation is more nuanced: the same type of modification at different positions can have opposite effects. For example, H3K4me3 (trimethylation of lysine 4 on histone H3) marks active gene promoters, while H3K27me3 (trimethylation of lysine 27) marks genes silenced by the Polycomb repressive complex. The position matters as much as the chemical group.
What makes this system truly powerful is its heritability. When a cell divides, histone modifications can be copied onto newly assembled nucleosomes, so daughter cells "remember" which genes were active or silent in the parent — without any change to the DNA sequence itself. This is the essence of epigenetic regulation: heritable changes in gene expression that operate above the level of the genetic code. A liver cell and a neuron carry identical DNA, but their distinct histone modification patterns ensure each cell type expresses the right set of genes.
When the enzymes that write, erase, or read histone marks malfunction, the consequences are severe. A histone methyltransferase that silences tumor suppressors via H3K27me3 can drive unchecked cell proliferation if it becomes overactive. This is why drugs targeting histone-modifying enzymes — particularly HDAC inhibitors and EZH2 inhibitors — have become important cancer therapeutics. Understanding the histone code is not just an academic exercise; it reveals a regulatory layer that sits between DNA sequence and gene expression, one that cells use to maintain identity and that disease can hijack.